A transesophageal echocardiographic study on risk factors for stroke in elderly patients with atrial fibrillation: A comparison with younger patients

Chest

Volumn 120, Issue 3, 2001, Pages 840-846

  Shinokawa, N ^a   Hirai, T ^a   Takashima, S ^a   Kameyama, T ^a   Nakagawa, K ^a   Asanoi, H ^a   Inoue, H ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Atrial fibrillation; Embolism; Transesophageal echocardiography

Indexed keywords

ADULT; AGE; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD FLOW VELOCITY; BRAIN EMBOLISM; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; UNIVERSITY HOSPITAL;

EID: 0034820610     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.3.840     Document Type: Article

References (29)

1. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
2. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
3. Warfarin vs aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study
4. Adjusted dose warfarin vs low intensity, fixed dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial
5. Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis
6. Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus
7. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo
8. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: Benefit of oral anticoagulants
9. Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: A multiplane transesophageal echocardiographic study
10. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: A new finding seen by transesophageal echocardiography
11. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke
12. Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic study
13. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease
14. Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force
15. A computed tomographic guide to the identification of cerebral vascular territories
16. Classification of cerebrovascular disease
17. Antithrombotic therapy in atrial fibrillation
18. Relation of transesophageal echocardiographic findings of subtypes of cerebral infarction in patients with atrial fibrillation
19. Carotid artery and heart disease in subtypes of cerebral infarction
20. Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces
21. Red cell aggregation as a cause of blood-flow echogenicity
22. Prognostic implications of left atrial spontaneous echo contrast in non-valvular atrial fibrillation
23. Spontaneous echocardiographic contrast in the thoracic aorta: Factors associated with its occurrence and its association with embolic events
24. Aortic plaque in atrial fibrillation; prevalence, predictors, and thromboembolic implications
25. Risk factors and atherosclerotic lesions: A review of autopsy studies
26. Aortic atherosclerotic plaques as a source of systemic embolism
27. Warfarin use among patients with atrial fibrillation
28. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation: Stroke Prevention in Atrial Fibrillation III Investigators
29. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A multicenter, prospective, randomized trial